Parallax Volatility Advisers, L.P. Neurocrine Biosciences Inc Transaction History

Parallax Volatility Advisers, L.P.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $228,326 - $267,476	2,481 Added 18.12%	16,173 $1.72 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $161,811 - $213,649	2,135 Added 18.47%	13,692 $1.34 Million
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $681,609 - $891,972	-9,408 Reduced 44.87%	11,557 $1.08 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $1.81 Million - $2.08 Million	20,965 New	20,965 $2.01 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $322,227 - $370,273	-3,739 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $334,378 - $382,387	3,739 New	3,739 $364,000
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $556,857 - $759,264	6,359 Added 175.52%	9,982 $971,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $874,123 - $1.19 Million	-9,982 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $314,874 - $392,479	3,623 New	3,623 $347,000
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $39,717 - $49,506	-457 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $43,945 - $61,763	457 New	457 $44,000
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $86 - $118	-1 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $151,881 - $183,918	-1,812 Reduced 99.94%	1 $0
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $18,992 - $34,572	-278 Reduced 13.3%	1,813 $129,000
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $122,386 - $162,240	2,091	2,091 $162,000

631

93.9M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.